| Dr Jason J Gruss, MD | |
|
4953 N Leavitt St, Chicago, IL 60625-1308 | |
| (773) 561-4038 | |
| Not Available |
| Full Name | Dr Jason J Gruss |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 21 Years |
| Location | 4953 N Leavitt St, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558574319 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| West Suburban Medical Center | Oak park, IL | Hospital |
| West Suburban Medical Ctr | Oak park, IL | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Rehabilitation Care Llc | 8628253259 | 17 |
News Archive
The human brain doesn't stop developing at adolescence, but continues well into our 20s, demonstrates recent research from the Faculty of Medicine & Dentistry at the University of Alberta.
BioCardia, Inc., focused on regenerative biologic therapies for cardiovascular disease, today announced positive results from a Phase 1/2 heart failure trial using the Company's Helical Infusion System, comprising the Helical Infusion System Catheter and Morph Vascular Access Catheter, to deliver allogeneic, or "off-the-shelf," and autologous, or from the treated patient, mesenchymal (adult) stem cells (MSCs) via transendocardial injection.
BioTime, Inc., Cell Cure Neurosciences Ltd., and Hadasit Bio-Holdings Ltd. jointly announced today that Cell Cure and Teva Pharmaceutical Industries Ltd. have entered into an exclusive license option agreement to develop and commercialize Cell Cure's OpRegen product for the treatment of age-related macular degeneration (AMD).
Over the decades, scientists have repeatedly shown that patients with increased levels of the hormone insulin in their blood can experience increased risks of cancer. Surprisingly, however, Joslin Diabetes Center researchers now have discovered that impaired effects of insulin also can boost these risks.
Due to overwhelming response from researchers, a second round of abstract submissions for the upcoming 2nd International Symposium on MR-guided Focused Ultrasound will open on Monday, August 23, 2010, nine days earlier than previously announced. The submission deadline will be moved forward to Monday, September 6, 2010.
› Verified 1 days ago
| Entity Name | Schwab Faculty Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902859861 PECOS PAC ID: 0244203032 Enrollment ID: O20040819000056 |
News Archive
The human brain doesn't stop developing at adolescence, but continues well into our 20s, demonstrates recent research from the Faculty of Medicine & Dentistry at the University of Alberta.
BioCardia, Inc., focused on regenerative biologic therapies for cardiovascular disease, today announced positive results from a Phase 1/2 heart failure trial using the Company's Helical Infusion System, comprising the Helical Infusion System Catheter and Morph Vascular Access Catheter, to deliver allogeneic, or "off-the-shelf," and autologous, or from the treated patient, mesenchymal (adult) stem cells (MSCs) via transendocardial injection.
BioTime, Inc., Cell Cure Neurosciences Ltd., and Hadasit Bio-Holdings Ltd. jointly announced today that Cell Cure and Teva Pharmaceutical Industries Ltd. have entered into an exclusive license option agreement to develop and commercialize Cell Cure's OpRegen product for the treatment of age-related macular degeneration (AMD).
Over the decades, scientists have repeatedly shown that patients with increased levels of the hormone insulin in their blood can experience increased risks of cancer. Surprisingly, however, Joslin Diabetes Center researchers now have discovered that impaired effects of insulin also can boost these risks.
Due to overwhelming response from researchers, a second round of abstract submissions for the upcoming 2nd International Symposium on MR-guided Focused Ultrasound will open on Monday, August 23, 2010, nine days earlier than previously announced. The submission deadline will be moved forward to Monday, September 6, 2010.
› Verified 1 days ago
| Entity Name | Advanced Rehabilitation Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285942722 PECOS PAC ID: 8628253259 Enrollment ID: O20110426000464 |
News Archive
The human brain doesn't stop developing at adolescence, but continues well into our 20s, demonstrates recent research from the Faculty of Medicine & Dentistry at the University of Alberta.
BioCardia, Inc., focused on regenerative biologic therapies for cardiovascular disease, today announced positive results from a Phase 1/2 heart failure trial using the Company's Helical Infusion System, comprising the Helical Infusion System Catheter and Morph Vascular Access Catheter, to deliver allogeneic, or "off-the-shelf," and autologous, or from the treated patient, mesenchymal (adult) stem cells (MSCs) via transendocardial injection.
BioTime, Inc., Cell Cure Neurosciences Ltd., and Hadasit Bio-Holdings Ltd. jointly announced today that Cell Cure and Teva Pharmaceutical Industries Ltd. have entered into an exclusive license option agreement to develop and commercialize Cell Cure's OpRegen product for the treatment of age-related macular degeneration (AMD).
Over the decades, scientists have repeatedly shown that patients with increased levels of the hormone insulin in their blood can experience increased risks of cancer. Surprisingly, however, Joslin Diabetes Center researchers now have discovered that impaired effects of insulin also can boost these risks.
Due to overwhelming response from researchers, a second round of abstract submissions for the upcoming 2nd International Symposium on MR-guided Focused Ultrasound will open on Monday, August 23, 2010, nine days earlier than previously announced. The submission deadline will be moved forward to Monday, September 6, 2010.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason J Gruss, MD 4953 N Leavitt St, Chicago, IL 60625-1308 Ph: (773) 561-4038 | Dr Jason J Gruss, MD 4953 N Leavitt St, Chicago, IL 60625-1308 Ph: (773) 561-4038 |
News Archive
The human brain doesn't stop developing at adolescence, but continues well into our 20s, demonstrates recent research from the Faculty of Medicine & Dentistry at the University of Alberta.
BioCardia, Inc., focused on regenerative biologic therapies for cardiovascular disease, today announced positive results from a Phase 1/2 heart failure trial using the Company's Helical Infusion System, comprising the Helical Infusion System Catheter and Morph Vascular Access Catheter, to deliver allogeneic, or "off-the-shelf," and autologous, or from the treated patient, mesenchymal (adult) stem cells (MSCs) via transendocardial injection.
BioTime, Inc., Cell Cure Neurosciences Ltd., and Hadasit Bio-Holdings Ltd. jointly announced today that Cell Cure and Teva Pharmaceutical Industries Ltd. have entered into an exclusive license option agreement to develop and commercialize Cell Cure's OpRegen product for the treatment of age-related macular degeneration (AMD).
Over the decades, scientists have repeatedly shown that patients with increased levels of the hormone insulin in their blood can experience increased risks of cancer. Surprisingly, however, Joslin Diabetes Center researchers now have discovered that impaired effects of insulin also can boost these risks.
Due to overwhelming response from researchers, a second round of abstract submissions for the upcoming 2nd International Symposium on MR-guided Focused Ultrasound will open on Monday, August 23, 2010, nine days earlier than previously announced. The submission deadline will be moved forward to Monday, September 6, 2010.
› Verified 1 days ago
Patrick Joseph Barrett, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 345 E Superior St, 16th Floor, Chicago, IL 60611 Phone: 312-238-2780 | |
Dr. Monica E Rho, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 355 E Erie St, Chicago, IL 60611 Phone: 312-238-1000 Fax: 312-238-7709 | |
Ms. Shivani Dua, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 885, Chicago, IL 60612 Phone: 312-942-2384 | |
Kara Eder, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 333 E Benton Pl Ste 108, Chicago, IL 60601 Phone: 312-929-3646 | |
Dr. Sonika Randev, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 401 N Michigan Ave Ste 1200, Chicago, IL 60611 Phone: 312-635-0973 | |
Lauren E Splittgerber, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 355 E Erie St, Chicago, IL 60611 Phone: 312-238-1000 Fax: 312-238-7767 | |
Reza Zayn Tanveer, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1620 W Harrison St, Chicago, IL 60612 Phone: 312-942-5000 |